store under nitrogen,keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 258.00 | |
5 mg | In stock | $ 642.00 | |
10 mg | In stock | $ 913.00 | |
25 mg | In stock | $ 1,370.00 | |
50 mg | In stock | $ 1,850.00 | |
100 mg | In stock | $ 2,500.00 | |
500 mg | In stock | $ 4,900.00 |
Description | Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis. |
In vivo | In 1457 patients (50 mg/day, n=485; 200 mg/day, n=486; placebo, n=486), 1048 (71.9%) completed the study. 56% had KLG3. In KLG2 patients, JSN after 48 weeks was lower with Cindunistat 50 mg/day versus placebo (p=0.032). Least-squares mean±SE JSN with Cindunistat 50 mg/day ( -0.048±0.028 mm) and 200 mg/day (-0.062±0.028 mm) were 59.9% (95% CI 6.8% to 106.9%) and 48.7% (95% CI -8.4% to 93.9%) of a placebo, improvement was not maintained at 96 weeks. No improvement was observed for KLG3 patients at either time point. Cindunistat did not improve joint pain or function but was generally well tolerated. Cindunistat (50 or 200 mg/day) did not slow the rate of JSN versus placebo. After 48 weeks, KLG2 patients showed less JSN.[1] |
Synonyms | Cindunistat free base, SD6010, SD-6010 |
Molecular Weight | 219.3 |
Formula | C8H17N3O2S |
CAS No. | 364067-22-1 |
store under nitrogen,keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (250.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cindunistat 364067-22-1 Immunology/Inflammation NOS Cindunistat free base SD 6010 SD6010 SD-6010 inhibitor inhibit